Showing 1081 to 1095 of 2042 results
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Quality policy
We are committed to providing quality services to our stakeholders, learning from feedback and driving continuous improvement.